Vanta Bioscience Share Price
19.56-1.02 (-4.96%)
-23.29% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SAGILITY-ANSE
SYNGENE-ANSE
INDGN-ANSE
IGIL-ANSE
NESCO-ANSE
JUSTDIAL-ANSE
LATENTVIEW-ANSE
CMSINFO-ANSE
MEDIASSIST-ANSE
AWFIS-ANSE
VANTABIO-MTNSE
Vanta Bioscience Share Price
19.56-1.02 (-4.96%)
-23.29% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | -32% | -41% | -80% |
| - | - | - | -54% |
| - | - | - | - |
| -28% | -41% | -69% | -104% |
Peer Comparison
Symbol
SAGILITY-A
SYNGENE-A
INDGN-A
IGIL-A
NESCO-A
JUSTDIAL-A
LATENTVIEW-A
CMSINFO-A
MEDIASSIST-A
AWFIS-A
VANTABIO-MT
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 44.9 | ₹21520 Cr | 21.67 | 0.46 | 3.18 | ₹925 Cr |
| 380.3 | ₹15404 Cr | 69.7 | -0.22 | 16.72 | ₹317 Cr |
| 592.9 | ₹14413 Cr | 35.95 | 4.83 | 22.82 | ₹401 Cr |
| 324.9 | ₹14356 Cr | 23.55 | 3.84 | 15.26 | ₹711 Cr |
| 1,078.6 | ₹7600 Cr | 18.25 | 14.19 | 66.2 | ₹413 Cr |
| 669.25 | ₹5896 Cr | 11.71 | 19.54 | 64.36 | ₹497 Cr |
| 245.8 | ₹5245 Cr | 26.84 | 2.33 | 11.49 | ₹198 Cr |
| 232.7 | ₹3748 Cr | 12.77 | 5.23 | 33.07 | ₹303 Cr |
| 319.05 | ₹2503 Cr | 26.85 | 3.71 | 23.84 | ₹88 Cr |
| 262.65 | ₹1925 Cr | 22.69 | 3.35 | 68.94 | ₹71 Cr |
| 19.56 | ₹15 Cr | 135.52 | 2.72 | 0.7 | ₹11 L |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — |
| ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr |
| ₹4 Cr | ₹9 Cr | ₹11 Cr | ₹18 Cr | ₹18 Cr | ₹17 Cr | ₹16 Cr |
| ₹4 Cr | ₹9 Cr | ₹11 Cr | ₹18 Cr | ₹18 Cr | ₹17 Cr | ₹16 Cr |
| ₹10 Cr | ₹15 Cr | ₹18 Cr | ₹24 Cr | ₹24 Cr | ₹23 Cr | ₹22 Cr |
| -₹7 Cr | -₹2 Cr | ₹1 Cr | ₹5 Cr | ₹2 Cr | ₹99 L | ₹98 L |
| ₹21 Cr | ₹29 Cr | ₹35 Cr | ₹29 Cr | ₹23 Cr | ₹13 Cr | ₹12 Cr |
| ₹33 Cr | ₹20 Cr | ₹12 Cr | ₹8 Cr | ₹5 Cr | ₹50 L | ₹0 |
| ₹1 Cr | ₹75 L | ₹97 L | ₹78 L | ₹72 L | ₹59 L | ₹40 L |
| ₹56 Cr | ₹50 Cr | ₹48 Cr | ₹38 Cr | ₹29 Cr | ₹14 Cr | ₹13 Cr |
| — | — | — | — | — | — | — |
| ₹5 Cr | ₹6 Cr | ₹4 Cr | ₹2 Cr | ₹47 L | ₹49 L | ₹46 L |
| ₹13 Cr | ₹12 Cr | ₹10 Cr | ₹9 Cr | ₹10 Cr | ₹7 Cr | ₹3 Cr |
| ₹8 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹0 |
| ₹0 | ₹65,040 | ₹0 | ₹8 L | ₹11 L | ₹24 L | ₹24 L |
| ₹27 Cr | ₹23 Cr | ₹18 Cr | ₹14 Cr | ₹15 Cr | ₹10 Cr | ₹3 Cr |
| ₹86 Cr | ₹85 Cr | ₹85 Cr | ₹81 Cr | ₹70 Cr | ₹49 Cr | ₹39 Cr |
| ₹70 Cr | ₹61 Cr | ₹57 Cr | ₹45 Cr | ₹36 Cr | ₹17 Cr | ₹13 Cr |
| — | — | — | — | — | — | — |
| ₹75 Cr | ₹69 Cr | ₹67 Cr | ₹41 Cr | ₹33 Cr | ₹23 Cr | ₹19 Cr |
| ₹19 Cr | ₹15 Cr | ₹10 Cr | ₹5 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr |
| ₹55 Cr | ₹54 Cr | ₹57 Cr | ₹36 Cr | ₹29 Cr | ₹21 Cr | ₹18 Cr |
| ₹0 | ₹0 | ₹0 | ₹23 Cr | ₹19 Cr | ₹7 Cr | ₹4 Cr |
| ₹65 L | ₹64 L | ₹73 L | ₹2 Cr | ₹97 L | ₹97 L | ₹35 L |
| ₹91 L | ₹91 L | ₹91 L | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹71 Cr | ₹68 Cr | ₹69 Cr | ₹67 Cr | ₹50 Cr | ₹29 Cr | ₹22 Cr |
| — | — | — | — | — | — | — |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2 Cr |
| ₹7 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹10 Cr | ₹14 Cr | ₹9 Cr |
| ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
| ₹22 L | ₹16 L | ₹10 L | ₹22 L | ₹3 Cr | ₹20 L | ₹3 Cr |
| ₹26 L | ₹20 L | ₹17 L | ₹21 L | ₹4 Cr | ₹2 Cr | ₹93 L |
| ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹2 Cr | ₹2 Cr | ₹22 L |
| ₹15 Cr | ₹17 Cr | ₹15 Cr | ₹15 Cr | ₹20 Cr | ₹20 Cr | ₹17 Cr |
| -₹11 Cr | -₹6 Cr | -₹3 Cr | ₹22 L | ₹5 Cr | ₹10 Cr | ₹14 Cr |
| ₹86 Cr | ₹85 Cr | ₹85 Cr | ₹81 Cr | ₹70 Cr | ₹49 Cr | ₹39 Cr |
| ₹17 | ₹24 | ₹28 | ₹38 | ₹38 | ₹37 | ₹35 |
| ₹17 | ₹24 | ₹28 | ₹38 | ₹38 | ₹37 | ₹35 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
| -₹13 Cr | -₹9 Cr | -₹10 Cr | ₹23 L | ₹59 L | ₹1 Cr | ₹1 Cr |
| ₹8 Cr | ₹10 Cr | ₹9 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
| ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr | -₹2 Cr | -₹5 Cr |
| -₹2 Cr | ₹3 Cr | -₹63 L | ₹5 Cr | ₹7 Cr | ₹2 Cr | -₹1 Cr |
| -₹2 Cr | ₹3 Cr | -₹63 L | ₹5 Cr | ₹7 Cr | ₹2 Cr | -₹1 Cr |
| -₹7 Cr | -₹3 Cr | -₹6 Cr | -₹17 Cr | -₹22 Cr | -₹7 Cr | -₹5 Cr |
| ₹9 Cr | ₹69 L | ₹6 Cr | ₹9 Cr | ₹18 Cr | ₹2 Cr | ₹10 Cr |
| ₹6 L | ₹6 L | -₹13 L | -₹2 Cr | ₹2 Cr | -₹3 Cr | ₹3 Cr |
| ₹16 L | ₹10 L | ₹22 L | ₹3 Cr | ₹20 L | ₹3 Cr | ₹9 L |
| ₹22 L | ₹16 L | ₹10 L | ₹22 L | ₹3 Cr | ₹20 L | ₹3 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Vanta Bioscience Share Price
19.56-1.02 (-4.96%)
-23.29% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 oscillators
RSI
39.45Sell
STOCH %K
13.97Buy
MACD Level(12,26)
-0.35Sell
Ultimate Oscillator
32.53Sell
Aroon Oscillator
62.00Buy
BOP
-1.00Sell
CCI
-105.50Buy
Williams %R
-86.03Buy
Momentum
-5.37Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 9 out of 9 moving averages
EMA 9
21.11Sell
SMA 9
21.28Sell
EMA 21
21.89Sell
SMA 21
22.96Sell
EMA 50
21.45Sell
SMA 50
20.40Sell
EMA 200
26.21Sell
SMA 200
23.15Sell
WMA 20
22.22Sell
Pivot
Pivot
Classic
Resistance 5
27.77
Resistance 4
25.81
Resistance 3
23.85
Resistance 2
21.89
Resistance 1
21.23
Pivot
19.93
Support 1
19.27
Support 2
17.97
Support 3
16.01
Support 4
14.05
Support 5
12.09
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Vanta Bioscience Share Price
19.56-1.02 (-4.96%)
-23.29% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Mar 2024 |
|---|---|---|---|---|---|
| 72.81% | 72.81% | 72.81% | 69.36% | 69.36% | 69.36% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 27.19% | 27.19% | 27.19% | 30.64% | 30.64% | 30.64% |
Bulk & block deals
Name
Emily Bosco Menezes
Bosco Armando Menezes
Inventure Growth & Securities Ltd.
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 13 Mar 2025 | Purchase | 19.60 L | ₹30.75 | 63.75 K | Bulk | 0.896372 | BSE |
| 13 Mar 2025 | Sell | 19.60 L | ₹30.75 | 63.75 K | Bulk | 0.896372 | BSE |
| 25 Jun 2018 | Sell | 30.32 L | ₹48.13 | 63 K | Bulk | 0.885827 | BSE |
Insider trading & SAST
Client name
Dopesh Raja Mulakala & Others
S Chandra Sekhar Rao
Dopesh Raja Mulakala
Chandra Shekar Rao Simhadri
Chandra Shekar Rao Simhadri
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 May 2025 | Promoter | Acquisition | 12.68 | 72.81 | 0 | — | 8 L | 06 May 2025 | Pref. Allotment | 51,78,000 | SAST | 29(2) | — |
| 09 May 2025 | Promoter | Acquisition | 5.624297 | 7.35 | 2 Cr | ₹50 | 4 L | 06 May 2025 | Preferential Offer | 5,22,500 | Insider Trading | — | Equity Shares |
| 09 May 2025 | Promoter & Director | Acquisition | 5.624297 | 12.06 | 2 Cr | ₹50 | 4 L | 06 May 2025 | Preferential Offer | 8,58,000 | Insider Trading | — | Equity Shares |
| 25 Jun 2022 | Promoter | Acquisition | 0.083175 | 1.82 | 5.18 L | ₹98.64 | 5.25 K | 21 Jun 2022 | Market Purchase | 1,15,000 | Insider Trading | — | Equity Shares |
| 21 Jun 2022 | Promoter | Acquisition | 0.154468 | 1.74 | 9.03 L | ₹92.60 | 9.75 K | 16 Jun 2022 - 20 Jun 2022 | Market Purchase | 1,09,750 | Insider Trading | — | Equity Shares |
Vanta Bioscience Share Price
19.56-1.02 (-4.96%)
-23.29% past 1 Year
Vanta Bioscience Ltd was Incrporated in the year of 2016. The company's product range includes Testing Analysis Service Charges. The company engages in the business of Research And Experimental Development
Corporate Actions
Date
Type
Details
Company details
Vanta Bioscience Share Price
19.56-1.02 (-4.96%)
-23.29% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Vanta Bioscience Share Price
19.56-1.02 (-4.96%)
-23.29% past 1 Year
News
Vanta Bioscience informs about disclosure
Equity
VANTABIO
Vanta Bioscience informs about submission of revised financial statements
Equity
VANTABIO
Vanta Bioscience bags order of Rs 1.2 crore from large Indian Multinational Company
Equity
VANTABIO
Vanta Bioscience gets order worth Rs 57 lakh
Equity
VANTABIO
Vanta Bioscience informs about disclosure
Equity
VANTABIO

